Concerns of Children Whose Parents Have Cystic Fibrosis
NCT ID: NCT04702386
Last Updated: 2025-11-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
27 participants
OBSERVATIONAL
2021-02-18
2022-02-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The current study (MucoKids) is an extension of the previous MucoPar study and aims to explore and collect the perceptions, expectations and needs of children whose one parent has CF.
This will be done in the context of individual interviews or in several small groups of children led by a psychologist who will encourage them to develop what constitutes to be the child of somebody with CF.
The collected information should make it possible to develop and propose adapted medico-psycho-social interventions, if necessary, in connection with patient associations.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Parenting Concerns in Patients With Cystic Fibrosis (MucoPar)
NCT04133246
Psychological Study in Children With Mucoviscidosis
NCT05948488
Response to CFTR Modulators in CF Patients Under 18 Years
NCT04301856
Impacts of the Covid-19 Epidemic and Associated Lockdown Measures on the Management, Health and Behaviors of Cystic Fibrosis Patients During the 2020 Epidemic
NCT04463628
Effect of Parental Attitude on Functional and Physical Level of Children With Cystic Fibrosis
NCT06306508
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
However, this question does not only concern parents and their spouses. It is also fundamental to take into account the experience of the children, to understand their experiences and their own needs in this context of serious illness of a parent with limited life expectancy.
Therefore, the purpose of this study is to explore and collect the perceptions, expectations and needs of children whose one parent has CF. Children are eligible from the age of 6 if their parents agree.
Children will have semi-structured individual interviews or will participate in focus groups with the study psychologist in order to express their feelings, difficulties, expectations and needs in living with a parent who has CF.
Thematic analysis of the content will first be done separately for individual interviews and focus groups, and a global synthesis will be carried out.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Focus groups
Children aged 8 years or more participating in a focus group with the study psychologist
Focus groups
Groups of 3 to 8 children led by the study psychologist lasting 1 hour for the 8-11-year-old children and up to 2 hours for the children of at least 12 years old, about being the child of a parent with CF
Individual interviews
Interview led by the psychologist about being the child of a parent with CF
Individual interviews
All children who have an individual interview with the study psychologist
Focus groups
Groups of 3 to 8 children led by the study psychologist lasting 1 hour for the 8-11-year-old children and up to 2 hours for the children of at least 12 years old, about being the child of a parent with CF
Individual interviews
Interview led by the psychologist about being the child of a parent with CF
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Focus groups
Groups of 3 to 8 children led by the study psychologist lasting 1 hour for the 8-11-year-old children and up to 2 hours for the children of at least 12 years old, about being the child of a parent with CF
Individual interviews
Interview led by the psychologist about being the child of a parent with CF
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have the authorization of the parent with CF if the child is an adult and of both parents for subjects less than 18 years old
* Be ay least 6 years old
* Have a good level of French and good speaking skills for adolescents and adults
* Have a level of French and oral expression skills adapted to their age group for the youngest
Exclusion Criteria
* Serious somatic disease not related to cystic fibrosis in their parents or themselves
6 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Grégory Lemarchal Association
UNKNOWN
URC-CIC Paris Descartes Necker Cochin
OTHER
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cécile FLAHAULT, PhD
Role: STUDY_CHAIR
Assistance Publique - Hôpitaux de Paris
Dominique HUBERT, MD
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique - Hôpitaux de Paris
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cochin Hospital
Paris, , France
Foch Hospital
Suresnes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
APHP190326
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.